Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Drug or technology

Spravato (Esketamine)

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 8, 2026 · PHASE 3 TRIAL

PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study

ClinicalTrials.gov

This is a phase 3 trial registration with no posted results; the study is actively recruiting and has not yet generated outcome data.

PreliminaryNCT06713616 Spravato (Esketamine)Racemic ketamine

Reported

Planned sample size400

PhasePhase 3

Primary outcome measureSelf-Reported Effectiveness at 30 days

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support